First experience with I-123-alpha-methyl-tyrosine SPECT in the 3-D radiation treatment planning of brain gliomas

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 2, 2000, Pages 517-526

  Grosu, Anca Ligia ^a   Weber, Wolfgang ^b   Feldmann, Horst Jürgen ^a   Wuttke, Birgit ^b   Bartenstein, Peter ^b   Gross, Markus W ^a   Lumenta, Christianto ^c   Schwaiger, Markus ^b   Molls, Michael ^a  

^a Klin Poliklin Strahlentherapie R   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c KLINIKUM BOGENHAUSEN   (Germany)

Author keywords

3D treatment planning; I 123 alpha methyl tyrosine; Malignant glioma; MRI; Radiotherapy; SPECT

Indexed keywords

GADOLINIUM; IODINE 123;

ARTICLE; ASTROCYTOMA; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHYLTYROSINES; MIDDLE AGED; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034192301     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00423-5     Document Type: Article

References (38)

1. Brada M. Back to the future - radiotherapy in high grade gliomas. Br J Cancer. 60:1989;1-4.
2. Fine H.A., Dear K.B., Loeffler J.S., Black P.M., Canelos G.P. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 71:1993;2585-2597.
3. Salcman M., Scholtz H., Kaplan R.S., Kulik S. Long-term survival in patients with malignant astrocytoma. Neurosurgery. 34:1994;213-219.
4. Massey V., Wallner K.E. Patterns of second recurrence of malignant astrocytomas. Int J Radiat Oncol Biol Phys. 18:1990;395-398.
5. Grosu A.L., Feldmann H.J., Albrecht C., Kneschaurek P., Wehrmann R., Gross M.W., Zimmermann F.B., Molls M. Three-dimensional treatment planning of brain tumors Advantages of the method and clinical results . Strahlenther Onkol. 174:1998;7-13.
6. Thornton A.F., Sandler H.M., Haken R.K.T., McShan D.L., Fraass B.A., La Vigne M.L., Yanke B.R. The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms. Int J Radiat Oncol Biol Phys. 24:1992;767-775.
7. Leibel S.A., Scott C.B., Loeffler J.S. Contemporary approaches to the treatment of malignant gliomas with radiation therapy. Semin Oncol. 21:1994;198-219.
8. Byrne T.N. Imaging of gliomas. Semin Oncol. 21:1994;162-171.
9. Kelly P.J., Daumas-Duport C., Kispert D.B. Imaged-based stereotaxic serial biopsies in untreated intracranial glial neoplasm. J Neurosurg. 66:1987;865-874.
10. Kelly P.J., Daumas-Duport C., Scheitauer B.W. Stereotactic histologic correlations of CT- and MRI- defined abnormalities in patients with glial neoplasms. Mayo Clin Proc. 62:1987;450-459.
11. Chamberlain M.C., Murovic J.A., Levin V.A. Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology. 38:1988;1371-1374.
12. Wilkins D.E., Raaphorst G.P., Saunders J.K., Sutherland G.R., Smith I.C.P. Correlation between Gd-enhancement MR imaging and histopathology in treated and untreated 9L rat brain tumors. Magnet Reson Imaging. 13:1995;89-96.
13. 124I-IMT and first clinical results . J Nucl Med. 31:1990;281-286.
14. Kawai K., Fujibaayaashi Y., Saji H., Yonekura Y., Konishi J., Kubodera A., Yokoyama A. A strategy for the study of cerebral amino acid transport using iodine-123-labeled amino acid radiopharmaceutical 3-iodo-alpha-methyl-L-tyrosine . J Nucl Med. 32:1991;819-824.
15. 123I)iodo-alpha-methyl tyrosine and SPECT. J Nucl Med. 30:1989;110-112.
16. 123I)iodo-alpha-methyl-tyrosine Competition with natural L-amino acids . J Nucl Med. 32:1991;1225-1228.
17. Pietrzyk U., Herholz K., Fink G., Jacobs A., Mielke R., Slansky I., Wurker M., Heiss W.D. An interactive technique for three-dimensional image registration Validation for PET, SPECT, MRI and CT brain studies . J Nucl Med. 35:1994;2011-2018.
18. Weber W.A., Wuttke B., Grosu A.L., Ziegler S.I., Reidl G., Feldmann H.J., Bartenstein P., Molls M., Schwaiger M. Magnetic resonance imaging (MRI) and SPECT using I-123-alpha-methyl-L-tyrosine (IMT) for delineation of gliomas. J Nucl Med. 40:1999;98.
19. Di Chiro G. Positron emission tomography using f-18 fluorodeoxyglucose in brain tumors A powerful diagnostic and prognostic tool . Invest Radiol. 22:1986;360-371.
20. Alavi J.B., Alavi A., Chawlik J., Kushner M., Powe J., Hickey W., Reivich M. Positron emission tomography in patients with glioma. Cancer. 62:1988;1074-1078.
21. Goldmann S., Levivier M., Pirotte B., Brucher J.M., Wikler D., Damhaut P., Stanus E., Brotchi J., Hildebrand J. Regional glucose metabolism and histopathology of gliomas A study based on positron emission tomography-guided stereotactic biopsy . Cancer. 78:1996;1098-1106.
22. Gross M.W., Weber W., Feldmann H.J., Bartenstein P., Schwaiger M., Molls M. The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas. Int J Radiat Oncol Biol Phys. 41:1998;989-995.
23. Herholz K., Hoelzer T., Bauer B., Schroeder R., Voges J., Ernestus R.-I., Mendoza G., Weber-Luxenburger G., Loettgen J., Thiel A., Wienhard K., Heiss W.D. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology. 50:1998;1316-1322.
24. Kaschten B., Stevenaert A., Sadzot B., Deprez M., Degueldre C., Del Fiore G., Luxen A., Reznik M. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med. 39:1998;778-785.
25. Mosskin M., Ericson K., Hindmarsh T., Holst H., Collins V.P., Bergström M., Eriksson L., Johnström P. Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol. 30:1989;225-232.
26. Ogawa T., Shishido F., Kanno I., Inugami A.S., Fujita H., Murakami M., Shimosegawa E., Ito H., Hatazawa J., Okudera T., Uemura K., Yasui N., Mineura K. Cerebral glioma Evaluation with methionine PET . Radiology. 186:1993;45-53.
27. 11C)-L-methionine uptake in cerebral gliomas A comparative study using SPECT and PET . J Nucl Med. 38:1997;517-522.
28. Weber W., Bartenstein P., Gross M.W., Kinzel D., Daschner D., Feldmann H.J., Reidel G., Ziegler S.I., Lumenta C., Molls M., Schwaiger M. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. J Nucl Med. 38:1997;802-808.
29. Wienhard K., Herholz K., Coenen H.H. Increased amino acid transport into brain tumors measured by PET of L-2-F-18-fluorotyrosine. J Nucl Med. 32:1991;1338-1346.
30. Pruim J., Willemsen A.T.M., Molenaar W.M. Brain tumors L-1-C-11-tyrosine PET for visualisation and quantification of protein synthesis rare . Radiology. 197:1995;221-226.
31. Woesler B., Kuwert T., Morgenroth C., Matheja P., Palkovic S., Schäfers M., Vollet B., Schäfers K., Lerch H., Brandau W., Samnick S., Wassmann H., Schober O. Non-invasive grading of primary brain tumors Results of a comparative study between SPET with 123-I-alpha-methyl tyrosine and PET with 18F-deoxyglucose . Eur J Nucl Med. 24:1997;428-434.
32. Kuwert T., Morgenroth C., Woesler B., Matheja P., Palkovic S., Vollet B., Samnick S., Maasjosthusmann U., Lerch H., Gildehaus F.J., Wassmann H., Schober O. Uptake of iodine-123-alpha-methyl-tyrosine by gliomas and non-neoplastic brain lesions. Eur J Nucl Med. 23:1996;1345-1353.
33. Kuwert T., Woesler B., Morgenroth C., Lerch H., Schäfers M., Palkovic S., Matheja P., Brandau W., Wassmann H., Schober O. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine. J Nucl Med. 39:1998;23-27.
34. Kuwert T., Probst-Cousin S., Woesler B., Morgenroth C., Lerch H., Matheja P., Palkovic S., Schäfers M., Wassmann H., Gullotta F., Schober O. Iodine-123-alpha-methyl tyrosine in gliomas Correlation with cellular density and proliferative activity . J Nucl Med. 38:1997;1551-1555.
35. Feldmann HJ, Grosu AL, Weber W, Bartenstein P, Gross MW, Schwaiger M, Molls M. The value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography for the treatment planning of malignant gliomas. Frontiers in radiation therapy oncology. Basel: Karger; 1999. p. 37-43.
36. Loeffler J.S., Alexander E. III, Hochberg F.H., Wen P.Y., Morris J.H., Schoene W.C., Siddon R.L., Morse R.H., Blanck P.M. Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys. 19:1990;1455-1462.
37. Loeffler J.S., Alexander E. III, Shea W.M. ; et al. Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol. 10:1992;1379-1385.
38. Sarkaria J.N., Mehta M.P., Loeffler J.S., Buatti J.M., Chappell R.J., Levin A.B., Alexander E. III, Friedmann W.A., Kinsella T.J. Radiosurgery in the initial management of malignant gliomas Survival comparison with the RTOG recursive partitioning analysis . Int J Radiat Oncol Biol Phys. 32:1995;931-941.